Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules

• Egile Nagusiak: Marco Costantini (Egilea), Andrea Callegaro (Egilea), Jiří Beran (Egilea), Valérie Berlaimont (Egilea), Ilaria Galgani (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2020-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

In tick-borne encephalitis (TBE)-endemic regions, long-term vaccination programs are efficient in preventing the disease. A booster dose of a polygeline-free inactivated TBE vaccine (Encepur Adults, GSK), administered approximately 3 years post-primary vaccination according to 1 of 3 licensed vaccin...